LG Chem first acquires commercialization approval of ‘etanercept’ biosimilar in Japan
LG Chem will enter the antibody biopharmaceutical market.
LG Chem announced ‘LBEC0101(Project Name),’ a biosimilar referencing ‘etanercept(original product name: Enbrel)’ for the treatment of rheumatoid arthritis, has acquired commercialization approval from the Japanese Ministry of Health, Labo...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
